Regione Del Veneto Azienda ULSS N 7 Pedemontana — Clinical Trial Site

9 Registered trials

5 Currently recruiting

Organisation

Regione Del Veneto Azienda ULSS N 7 Pedemontana

Location

Bassano Del Grappa, Italy

Identifier

ORG-100042689

Address

Via Dei Lotti 40, 36061, Italy

Departments

2064:U.O.C. Oncoematologia
2401:U.O.C. Oncoematologia
4402: U.O.C. Oncoematologia
Medical oncology
Ospedale San Bassiano UOC Oncoematologia
UO Oncoematologia
UOC Nephrology and Dialysis
Urology
Via Dei Lotti, 40 , Urologia, Bassano del Grappa , Vicenza, 36061, IT

Clinical trials at this site (9)

Search interface

A study to assess the Efficacy and Safety of Efgartigimod IV in Adult Participants with Primary Immune Thrombocytopenia Recruiting

2024-515451-38-00 Primary Immune thrombocytopenia (ITP) 5 2025-02-27
A study of efficacy and safety of ianalumab in previously treated patients with warm autoimmune haemolytic anaemia Recruiting

2024-510635-21-00 warm autoimmune haemolytic anaemia (wAIHA) 5 2023-05-09
A trial to learn how well baxdrostat with dapagliflozin works compared to dapagliflozin on clinical outcomes alone and how safe it is in adu… Recruiting

2023-506460-14-00 Chronic kidney disease (CKD) and hypertension. 5 2025-05-07
Phase III study in mCRC patients with RAS/BRAF wild type tissue and RAS/BRAF mutated in LIquid BIopsy to compare in first-line therapy FOLFI… Recruiting

2024-517863-22-00 Study population consists in patients with a diagnosis 5 2024-12-01
Surgical treatment with or without apalutamide in subjects with high risk prostate cancer who are candidates for radical prostatectomy and s… Recruiting

2024-515049-41-00 metastatic prostate cancer 4 2024-07-12
A Long term Safety and Efficacy Study of Danicopan as an Add-on Therapy to C5i in Patients with PNH. Ended

2023-504867-18-00 Patients with Paroxysmal Nocturnal Hemoglobinuria 5 2022-12-05
Long-term safety and tolerability of iptacopan in patients with Paroxysmal Nocturnal Hemoglobinuria Ended

2023-509843-28-00 Paroxysmal Nocturnal Hemoglobinuria (PNH) 5 2021-11-10
A study of androgen deprivation therapy (ADT) plus apalutamide in patients with prostate cancer Ended

2023-506153-38-00 High-risk localized or locally advanced prostate cancer 5 2019-07-11
A multicenter, single arm, open-label trial to evaluate efficacy and safety of oral, twice daily iptacopan in adult PNH patients who have Hb… Ended

2022-502148-10-00 Paroxysmal Nocturnal Hemoglobinuria (PNH) 5 2023-10-10